Literature DB >> 30599167

Far-Infrared Spectroscopy as a Probe for Polymorph Discrimination.

Kuthuru Suresh1, Jeffrey S Ashe1, Adam J Matzger2.   

Abstract

Pharmaceutical crystalline polymorph and amorphous form detection and quantification is a standard requirement in the pharmaceutical industry. Infrared (IR) spectroscopy provides an important probe for the characterization of polymorphs. Nonetheless, characterization and discrimination among polymorphs using mid-IR spectroscopy is not always possible in part because the technique mainly probes vibrational modes arising from functional groups in the sample. In the present work, far-IR spectroscopy is demonstrated for the discrimination of polymorphs. This region is influenced by delocalized lattice vibrational modes derived from intermolecular forces and packing arrangements in the crystal structure. A total of 10 polymorphic pharmaceuticals were prepared to conduct a critical evaluation of the question, does this far-IR region add value for polymorph differentiation? It is demonstrated that the far-IR region offers high discriminating power for polymorphs compared to the mid-IR spectral region. In addition, structural similarity and dissimilarity in polymorphic packing arrangements can be derived from this analysis.
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amorphous; crystal packing; far-IR spectroscopy; pharmaceuticals; polymorph

Mesh:

Year:  2018        PMID: 30599167      PMCID: PMC6486452          DOI: 10.1016/j.xphs.2018.12.020

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  21 in total

1.  Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine.

Authors:  M M Lowes; M R Caira; A P Lötter; J G Van der Watt
Journal:  J Pharm Sci       Date:  1987-09       Impact factor: 3.534

2.  The use of polymer heteronuclei for crystalline polymorph selection.

Authors:  Meidong Lang; Adam L Grzesiak; Adam J Matzger
Journal:  J Am Chem Soc       Date:  2002-12-18       Impact factor: 15.419

3.  Using terahertz pulsed spectroscopy to quantify pharmaceutical polymorphism and crystallinity.

Authors:  Clare J Strachan; Philip F Taday; David A Newnham; Keith C Gordon; J Axel Zeitler; Michael Pepper; Thomas Rades
Journal:  J Pharm Sci       Date:  2005-04       Impact factor: 3.534

4.  Characterization of temperature-induced phase transitions in five polymorphic forms of sulfathiazole by terahertz pulsed spectroscopy and differential scanning calorimetry.

Authors:  J Axel Zeitler; David A Newnham; Philip F Taday; Terry L Threlfall; Robert W Lancaster; Rolf W Berg; Clare J Strachan; Michael Pepper; Keith C Gordon; Thomas Rades
Journal:  J Pharm Sci       Date:  2006-11       Impact factor: 3.534

Review 5.  Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement.

Authors:  Bradley Scott; Anne Wilcock
Journal:  PDA J Pharm Sci Technol       Date:  2006 Jan-Feb

6.  Crystalline polymorph selection and discovery with polymer heteronuclei.

Authors:  Christopher P Price; Adam L Grzesiak; Adam J Matzger
Journal:  J Am Chem Soc       Date:  2005-04-20       Impact factor: 15.419

7.  Form IV of carbamazepine.

Authors:  Meidong Lang; Jeff W Kampf; Adam J Matzger
Journal:  J Pharm Sci       Date:  2002-04       Impact factor: 3.534

8.  Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.

Authors:  J Axel Zeitler; Karin Kogermann; Jukka Rantanen; Thomas Rades; Philip F Taday; Michael Pepper; Jaakko Aaltonen; Clare J Strachan
Journal:  Int J Pharm       Date:  2006-10-21       Impact factor: 5.875

9.  Infrared studies of the polymorphic states of the fenamates.

Authors:  R K Gilpin; W Zhou
Journal:  J Pharm Biomed Anal       Date:  2004-12-24       Impact factor: 3.935

10.  Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I.

Authors:  Adam L Grzesiak; Meidong Lang; Kibum Kim; Adam J Matzger
Journal:  J Pharm Sci       Date:  2003-11       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.